Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 20, 2022

SELL
$25.61 - $41.78 $10,064 - $16,419
-393 Closed
0 $0
Q3 2021

Nov 01, 2021

BUY
$19.65 - $27.99 $1,080 - $1,539
55 Added 16.27%
393 $9,000
Q2 2021

Aug 02, 2021

BUY
$17.48 - $25.46 $821 - $1,196
47 Added 16.15%
338 $8,000
Q1 2021

Apr 22, 2021

SELL
$18.08 - $28.8 $7,846 - $12,499
-434 Reduced 59.86%
291 $7,000
Q4 2020

Jan 27, 2021

SELL
$11.7 - $23.41 $42,389 - $84,814
-3,623 Reduced 83.33%
725 $16,000
Q3 2020

Oct 26, 2020

BUY
$11.21 - $13.82 $43,606 - $53,759
3,890 Added 849.34%
4,348 $51,000
Q2 2020

Jul 22, 2020

BUY
$9.8 - $12.77 $4,488 - $5,848
458 New
458 $5,000

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $335M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track High Mark Wealth Management LLC Portfolio

Follow High Mark Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Mark Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Mark Wealth Management LLC with notifications on news.